Clinical Trials Logo

Hepato-splenomegaly clinical trials

View clinical trials related to Hepato-splenomegaly.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02298647 Withdrawn - Seizures Clinical Trials

Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)

BioGM1/BioGM2
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the ear-ly and sensitive diagnosis of GM1/GM2 from blood

NCT ID: NCT01457443 Withdrawn - Lung Disease Clinical Trials

Biomarker for Pompe Disease (BioPompe)

BioPompe
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Pompe disease from blood (plasma)